CANCER AND LEUKEMIA GROUP B--RPCI/SUNYAB

癌症和白血病 B 组--RPCI/SUNYAB

• 批准号: 6172507
• 负责人: ELLIS G LEVINE
• 金额: $ 28.13万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-04-15 至 2003-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6172507
• 关键词: AIDS related neoplasm /cancer; aging; antineoplastics; bone marrow transplantation; breast neoplasms; cancer prevention; cancer registry /resource; carmustine; chemoprevention; cis platinum compound; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; doxorubicin; drug resistance; finasteride; fluorouracil; gastrointestinal neoplasms; health care cost /financing; hormone therapy; human genetic material tag; human subject; human therapy evaluation; interleukin 2; leucovorin; leukemia; lymphoma; melanoma; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer epidemiology; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer vaccine; oncology nursing; paclitaxel; pathology; prostate neoplasms; psychology; quality of life; respiratory neoplasm; tamoxifen; tissue resource /registry; weight loss

DESCRIPTION (Adapted from applicant's abstract): Roswell Park Cancer Institute (RPCI) is requesting support to continue its participation in the Cancer and Leukemia Group B (CALGB). The goals of our participation in CALGB include the following: (1) to continue our strong contribution to the scientific agenda of the group, (2) to continue our performance of pilot activity at the local level that can be considered for group adaption, (3) to continue our administrative support for the efficient functioning of the group, (4) to sustain accrual in order to allow the rapid accumulation of clinical data and experience through the cooperative group process, and (5) to continue to provide data of high quality in a timely manner. Over the last 3-plus years during which we have had funding, we have contributed substantially to the scientific, administrative, core, and publication activities of the CALGB. More specifically, five RPCI members serve or have served as chairs or vice chairs of scientific committee; 22 serve or have served as members on 33 scientific committees; 14 serve or have served as study chairs on 21 protocols; 7 provide or have provided core services to the Group; and 5 have performed pilot studies that have led to the development of CALGB protocols, 3 have protocols pending activation, and 3 have submitted concepts for development. Moreover, RPCI members have contributed to 111 publications and given over 70 educational sessions. Furthermore, several members have administrative roles in the Group. Accrual is customarily between 150-200 credits/year. Data quality and timeliness of submission is regularly cited by the Group's quality assurance committee as among the best in the Group. Continued funding should allow us to sustain the vigor of our activities and therefore meet our specific aims. Founded in 1898, RPCI was one of the first institutions dedicated exclusively to the research and treatment of cancer and allied diseases. The campus spans 25 acres in downtown Buffalo and consists of 15 research and clinical buildings with approximately one million square feet of space. Projected statistics for fiscal year 1996-1997 include 2381 new cancer cases, 5300 hospital admissions, and 104,000 outpatient visits from patients in 42 states and 22 foreign countries. The Institute is currently undergoing a $241 million modernization of its facilities. When completed in 1998, Roswell Park will have a new 133 bed hospital, a diagnostic and treatment center, outpatient clinics, and medical research laboratories, as well as renovated education, research, and support space.

描述（改编自申请人的摘要）：罗斯威尔公园癌 研究所（RPCI）要求支持继续参与 癌症和白血病B（CALGB）。 我们参与的目标 CALB包括以下内容：（1）继续我们对 该小组的科学议程，（2）继续我们的飞行员表现 可以考虑进行组适应的地方的活动，（3） 为了继续我们的管理支持 组，（4）维持应计，以允许快速积累 通过合作小组流程和（5）的临床数据和经验 继续及时提供高质量的数据。 在 在我们获得资金的最后3年以上，我们做出了贡献 基本上是科学，行政，核心和出版物 CALB的活动。 更具体地说，五个RPCI成员服务或拥有 担任科学委员会的主席或副主席； 22服务或 担任33个科学委员会成员； 14发出或曾为 研究椅子上的21个方案； 7提供或提供核心服务 小组； 5进行了试点研究，导致了 制定CALB协议，3个具有待处理的协议，3个协议 已经提交了开发概念。 此外，RPCI成员有 为111个出版物做出了贡献，并进行了70多个教育课程。 此外，几个成员在小组中担任行政角色。 应计费通常在每年150-200的学分之间。 数据质量和 该小组的质量保证经常引用提交的及时性 委员会是该小组中最好的委员会之一。 持续的资金应该允许我们 维持我们活动的活力，因此实现我们的具体目标。 RPCI成立于1898年，是最早专门的机构之一 专门研究癌症和盟友疾病的研究和治疗。 校园占地25英亩，位于布法罗市中心，由15个研究组成 和大约一百万平方英尺的空间。 1996-1997财政年度的预计统计数据包括2381个新癌症 病例，5300例医院入院和104,000例患者的门诊就诊 在42个州和22个国外。 该研究所目前是 进行了2.41亿美元的现代化设施。 完成后 1998年，罗斯威尔公园（Roswell Park）将有一家新的133张床医院，诊断和 治疗中心，门诊诊所和医学研究实验室 以及翻新的教育，研究和支持空间。